Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Blast Crisis × Erlotinib Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 2 Lung Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

Cyclophosphamide 3 Methotrexate 2 ponatinib 1 pegfilgrastim 1 nilotinib 1 merphos 1 fludarabine 1 bosutinib 1 blinatumomab 1 belinostat 1 asciminib 1 adavosertib 1 Vorinostat 1 Vincristine 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Succimer 1 Specimen Handling 1 Rituximab 1 Polymerase Chain Reaction 1 Pentetic Acid 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Magnetic Resonance Spectroscopy 1 Imatinib Mesylate 1 Granulocyte Colony-Stimulating Factor 1 Geritol 1 Ganciclovir 1 Foscarnet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡